4SCAR-CD44v6 T Cell Therapy / SZGIMI 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
4SCAR-CD44v6 T Cell Therapy / SZGIMI
NCT04427449: 4SCAR-CD44v6 T Cell Therapy Targeting Cancer

Recruiting
1/2
100
RoW
CD44v6-specific CAR gene-engineered T cells
Shenzhen Geno-Immune Medical Institute, Shenzhen Hospital of Southern Medical University, The Seventh Affilliated Hospital, Sun Yat-Sen University, Shenzhen Children's Hospital
Cancers Which Are CD44v6 Positive
05/23
12/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
4SCAR-CD44v6 T Cell Therapy / SZGIMI
NCT04427449: 4SCAR-CD44v6 T Cell Therapy Targeting Cancer

Recruiting
1/2
100
RoW
CD44v6-specific CAR gene-engineered T cells
Shenzhen Geno-Immune Medical Institute, Shenzhen Hospital of Southern Medical University, The Seventh Affilliated Hospital, Sun Yat-Sen University, Shenzhen Children's Hospital
Cancers Which Are CD44v6 Positive
05/23
12/23

Download Options